Healthline: Rates of IBD including Crohn’s Disease are three times higher than realized
UC digestive diseases expert discusses treatment options
A journalist for Healthline spoke with Loren Brook, MD, an assistant professor in the UC Department of Internal Medicine, about possible treatments for inflammatory bowel disease (IBD). In 2015, more than 3 million U.S. adults reported a diagnosis of IBD, an ongoing inflammation of all or part of the digestive tract, and includes two conditions, Crohn’s Disease and ulcerative colitis.
Brook, also a UC Health physician, explained the disease is usually lifelong but can be managed with relatively minor anti-inflammatory drugs such as oral mesalamine to immune-suppressing medications such as Remicade or steroids.
Related Stories
UC discovery points to new approach for treating diabetes — no insulin required
November 19, 2026
University of Cincinnati researchers identified a previously unknown insulin-independent pathway for glucose uptake in skeletal muscle, a discovery that could guide future treatments for diabetes, insulin resistance and high blood sugar.
Certain saturated fats may turn a ketogenic diet inflammatory
November 19, 2026
Medical News Today and MSN highlighted a University of Cincinnati Cancer Center study led by Director David Gius, MD, PhD, that found a ketogenic diet high in long-chain saturated fatty acids can increase inflammation.
Dealing with seasonal affective disorder
November 18, 2026
Fewer daylight hours can make it more difficult for those who experience seasonal affective disorder. Cincinnati Edition on 91.7 WVXU News/Cincinnati Public Radio recently discussed ways to monitor mental health as the days grow shorter. Ann Romaker, MD, of the University of Cincinnati College of Medicine, a professor of clinical medicine in the Division of Pulmonary, Critical Care and Sleep Medicine within the Department of Internal Medicine and the medical director of UC Health's Sleep Medicine program, joined the discussion.